These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 25260306)

  • 21. Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications.
    Sartorius K; Sartorius B; Aldous C; Govender PS; Madiba TE
    Cancer Epidemiol; 2015 Jun; 39(3):284-90. PubMed ID: 25922178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of gastrointestinal and liver tumors.
    Herszényi L; Tulassay Z
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):249-58. PubMed ID: 20496531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing pattern of epidemiology in hepatocellular carcinoma.
    Nordenstedt H; White DL; El-Serag HB
    Dig Liver Dis; 2010 Jul; 42 Suppl 3(Suppl 3):S206-14. PubMed ID: 20547305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etiological and molecular profile of hepatocellular cancer from India.
    Asim M; Sarma MP; Kar P
    Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of liver cancer: an overview.
    Srivatanakul P; Sriplung H; Deerasamee S
    Asian Pac J Cancer Prev; 2004; 5(2):118-25. PubMed ID: 15244512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan.
    Chen CT; Chen JY; Wang JH; Chang KC; Tseng PL; Kee KM; Chen PF; Tsai LS; Chen SC; Lin SC; Lu SN
    Kaohsiung J Med Sci; 2013 Aug; 29(8):451-9. PubMed ID: 23906236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidemiology, natural history, and risk factors of hepatocellular carcinoma].
    Fares N; Péron JM
    Rev Prat; 2013 Feb; 63(2):216-7, 220-2. PubMed ID: 23513788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epidemiology of hepatocellular carcinoma].
    Okuda K
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1105-15. PubMed ID: 8751796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies.
    Tung HD; Wang JH; Tseng PL; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen YD; Lu SN
    Am J Gastroenterol; 2010 Mar; 105(3):624-31. PubMed ID: 20051944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current epidemiology in hepatocellular carcinoma.
    Konyn P; Ahmed A; Kim D
    Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1295-1307. PubMed ID: 34624198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
    Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
    Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort.
    Setiawan VW; Wei PC; Hernandez BY; Lu SC; Monroe KR; Le Marchand L; Yuan JM
    Cancer; 2016 May; 122(9):1444-52. PubMed ID: 26916271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).
    Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ
    J Hepatol; 2016 Dec; 65(6):1086-1093. PubMed ID: 27569777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma in an Australian tertiary referral hospital 1975-2002: change in epidemiology and clinical presentation.
    Roberts SK; Kemp W
    J Gastroenterol Hepatol; 2007 Feb; 22(2):191-6. PubMed ID: 17295870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.
    Kirk GD; Lesi OA; Mendy M; Akano AO; Sam O; Goedert JJ; Hainaut P; Hall AJ; Whittle H; Montesano R
    Hepatology; 2004 Jan; 39(1):211-9. PubMed ID: 14752840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of environmental factors in the etiology of hepatocellular carcinoma].
    Tornai I
    Orv Hetil; 2010 Jul; 151(28):1132-6. PubMed ID: 20570793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma in Asia: Prevention strategy and planning.
    Ashtari S; Pourhoseingholi MA; Sharifian A; Zali MR
    World J Hepatol; 2015 Jun; 7(12):1708-17. PubMed ID: 26140091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatocellular carcinoma in Korea: introduction and overview].
    Park JW
    Korean J Gastroenterol; 2005 Apr; 45(4):217-26. PubMed ID: 15843747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.